MICRO IMAGE TECHNOLOGIES, INC. v. OLYMPUS CORPORATION OF THE AMERICAS

CourtDistrict Court, D. New Jersey
DecidedNovember 22, 2022
Docket3:20-cv-18781
StatusUnknown

This text of MICRO IMAGE TECHNOLOGIES, INC. v. OLYMPUS CORPORATION OF THE AMERICAS (MICRO IMAGE TECHNOLOGIES, INC. v. OLYMPUS CORPORATION OF THE AMERICAS) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
MICRO IMAGE TECHNOLOGIES, INC. v. OLYMPUS CORPORATION OF THE AMERICAS, (D.N.J. 2022).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

MICRO IMAGE TECHNOLOGIES, INC.,

Plaintiff, Civil Action No. 20-18781 (ZNQ) (TJB) v. OPINION OLYMPUS CORPORATION OF THE AMERICAS, et al.,

Defendants.

QURAISHI, District Judge THIS MATTER comes before the Court upon a Motion to Dismiss (“Motion,” ECF No. 13) filed by Defendants Olympus Corporation of the Americas and Morgan Sandell (collectively, the “Defendants”). In support of their Motion, Defendants filed a Moving Brief. (“Moving Br.”, ECF No. 13-1.) Plaintiff Micro Image Technologies, Inc. (“Plaintiff”) filed a brief in Opposition to Defendants’ Motion (“Opp’n,” ECF No. 14) to which Defendants replied (“Reply,” ECF No. 15). The Court has carefully considered the parties’ submissions and decides the Motion without oral argument pursuant to Federal Rule of Civil Procedure 78 and Local Civil Rule 78.1. For the reasons set forth below, the Court will DENY Defendants’ Motion with respect to Count I and GRANT Defendants’ Motion with respect to Counts II and IV. I. BACKGROUND AND PROCEDURAL HISTORY Plaintiff initiated this action on December 11, 2020, and Defendants originally moved to dismiss that Complaint on February 19, 2021. Plaintiff responded by filing an Amended Complaint on March 12, 2021. (“Am. Compl.”, ECF No. 9.) The Amended Complaint alleges

that Plaintiff is a distributor of medical devices that also provides the sales and installation of medical equipment through its sales/service representatives. (Id. ¶¶ 7,9.) Plaintiff’s “flagship product line, which represents a substantial portion of its revenue, is Carl Zeiss Surgical Microscopes. This is a very specialized segmented niche market” with only two main competitors; one of which is Defendant Olympus Corporation of the Americas (“Olympus”). (Id. ¶¶ 11–12.) Olympus manufactures, distributes, and markets for sale, among other things, an exoscope for use in the surgical theater known as the ORBEYE which directly competes with the Carl Zeiss product known as the KINEVO exoscope. Plaintiff depends on sales representatives to sell and market its goods. (Id. ¶ 17.) Co-Defendant Morgan Sandell (“Sandell”) was one of the sales representatives that Plaintiff employed. (Id. ¶ 18.) “The Sales Representatives, including Sandell, attended regular

business meetings to confer and strategize on topics including customer identification, sales strategies, business plans, and related topics.” (Id.) “Each sales representative is and was aware of and familiar with the identity of existing and potential customers, contacts and leads not only for his or her own Geography, but the Geography of all other Sales Representatives as well.” (Id.) As a result of the nature of these products and the niche market to which they belong, it is a small, closed universe of customers and potential customers, all of whom the Sales Representatives know. (Id. ¶ 24.) Sandell was hired by Plaintiff in 2009 as a sales representative and executed an employment agreement dated October 1, 2013. (Id. ¶¶ 27–28.) Sandell executed a Confidentiality and Noncompetition Agreement dated October 1, 2014 (the “Noncompetition Agreement”). (Id. ¶ 29.) In his role, Sandell had access to confidential and proprietary information about Plaintiff’s business, its products, customers, marketing, sales strategies, and business plans throughout the entire geography. (Id. ¶ 31.) The nonsolicitation and noncompetition provisions of Sandell’s

Noncompetition Agreement were limited to the sales region to which he was assigned, namely, Eastern Massachusetts and Rhode Island. (Id. ¶¶ 34–35.) Specifically, these clauses barred Sandell from participating in any capacity that would be in competition to Plaintiff in all geographic areas covered by Plaintiff in the 18 months prior to the date of termination, for 18 months following his termination. (Id. ¶ 41.) In October 2020, Sandell resigned from Plaintiff’s business and started working for Defendant-competitor Olympus. (Id. ¶¶ 45–47.) Sandell’s territory in his new position at Defendant Corporation includes Maine, Vermont, New Hampshire, Massachusetts, Connecticut, and Rhode Island with the exception of some parts in Eastern Massachusetts, Rhode Island, New York, and New Jersey. (Id. ¶ 49.) The Olympus territory currently occupied by Sandell overlaps a territory in which Plaintiff sells its products and includes

a portion of the initial territory in which Sandell marketed and sold products on behalf of Plaintiff, which puts him in breach of the Noncompetition Agreement. (Id. ¶¶ 50–51.) As a result, Plaintiff is claiming that Sandell’s actions breached the Noncompetition Agreement (Count I) and further tortiously interfered with the parties’ contract (Count II) and Plaintiff’s prospective economic advantage (misnumbered as Count IV).1 (Id. at 55–69.) Defendants initially filed an Opposition to the Amended Complaint on March 22, 2021, and thereafter filed a Motion to Dismiss the Amended Complaint on April 26, 2021. In its Moving Brief, Defendants argue that the Amended Complaint fails to state facts necessary to plausibly

1 As Defendants point out (Opp. Br. at 1 n.1), the Amended Complaint only contains three counts, misnumbered as Counts I, II, and IV. state a claim. (Moving Br. at 1.) Specifically, with respect to Plaintiff’s claims that Sandell breached the Noncompetition Agreement, the Amended Complaint fails to allege or describe how Sandell’s alleged conduct has caused it damages of any kind or any instances where Sandell solicited its customers. (Id. at 2.) Plaintiff only makes conclusory allegations that Defendants

“acted with malice and with intent to interfere” with Sandell’s contract and Plaintiff’s unspecified “economic relationships with its customers, manufacturers, and vendors.” (Id.) Lastly, Plaintiff’s tortious interference claims fail because Plaintiff merely recites the elements of those claims without any supporting facts or evidence of malice. (Id. at 12.) Plaintiff filed its Brief in Opposition to Defendants’ Motion to Dismiss. (ECF No. 24.) In its Opposition Brief, Plaintiff argues that Defendants’ admission that it hired Sandell to sell a competing product in a similar region is enough to state a plausible claim and overcome a Rule 12(b)(6) challenge. (Opp’n at 1.) Moreover, Plaintiff contends that it does not need to plead a precise amount of damages at this early stage of litigation to sufficiently allege damages. (Id. at 8.) Rather, Defendant Corporation “employing Sandell to sell a product that directly competes

with the same product Sandell sold on behalf of Plaintiff, in the same Geography where Sandell worked for Plaintiff . . . causes Sandell to breach his Noncompetition Agreement. . . per se, causes [Plaintiff] damages.” (Id.) Plaintiff maintains it has also sufficiently pled that Defendants acted with malice with respect to the tortious interference claim because surely Defendants knew that Sandell was previously employed at a competitor corporation selling a comparable product. (Id. at 10.) Plaintiff has also sufficiently alleged prospective economic advantage and a reasonable probability of receiving an economic benefit because Plaintiff has a legitimate interest in protecting its trade secrets, confidential business information, and customer relationships. (Id. at 11.) “It is those customer relationships, and sales to those customers, that [Plaintiff] sought to protect by entering into the post-employment restrictive covenants in the Noncompetition Agreement with Sandell.” (Id. at 12.) Thus, Sandell’s breach of that Noncompetition Agreement to sell a competing product for one of its only competitors in the area is sufficient to allege prospective economic advantage and a reasonable probability of receiving an economic benefit.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Coyle v. Englander's
488 A.2d 1083 (New Jersey Superior Court App Division, 1985)
Avtec Industries, Inc. v. Sony Corp. of America
500 A.2d 712 (New Jersey Superior Court App Division, 1985)
Sandler v. Lawn-A-Mat Chem. & Equip. Corp.
358 A.2d 805 (New Jersey Superior Court App Division, 1976)
Nappe v. Anschelewitz, Barr, Ansell & Bonello
477 A.2d 1224 (Supreme Court of New Jersey, 1984)
Cox v. Simon
651 A.2d 476 (New Jersey Superior Court App Division, 1995)
Cohn v. Fisher
287 A.2d 222 (New Jersey Superior Court App Division, 1972)
Printing Mart-Morristown v. Sharp Electronics Corp.
563 A.2d 31 (Supreme Court of New Jersey, 1989)
Harper-Lawrence v. United Merchants
619 A.2d 623 (New Jersey Superior Court App Division, 1993)
Harper-Lawrence v. United Merchants and Manufacturers
634 A.2d 522 (Supreme Court of New Jersey, 1993)
Di Cristofaro v. Laurel Grove Memorial Park
128 A.2d 281 (New Jersey Superior Court App Division, 1957)
Ideal Dairy Farms, Inc. v. Farmland Dairy Farms, Inc.
659 A.2d 904 (New Jersey Superior Court App Division, 1995)
Nostrame v. Santiago
61 A.3d 893 (Supreme Court of New Jersey, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
MICRO IMAGE TECHNOLOGIES, INC. v. OLYMPUS CORPORATION OF THE AMERICAS, Counsel Stack Legal Research, https://law.counselstack.com/opinion/micro-image-technologies-inc-v-olympus-corporation-of-the-americas-njd-2022.